We are live on ! Find out more
TAK icon

Takeda Pharmaceutical
TAK

358 hedge funds and large institutions have $1.82B invested in Takeda Pharmaceutical in 2026 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 174 increasing their positions, 58 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,078% more call options, than puts

Call options by funds: $30.6M | Put options by funds: $1.41M

200% more repeat investments, than reductions

Existing positions increased: 174 | Existing positions reduced: 58

47% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 38

39% more capital invested

Capital invested by funds: $1.31B → $1.82B (+$511M)

3% more funds holding

Funds holding: 348 → 358 (+10)

0.45% more ownership

Funds ownership: 2.63% → 3.09% (+0.45%)

Holders
358
Holders Change
+10
Holders Change %
+2.87%
% of All Funds
4.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
56
Increased
174
Reduced
58
Closed
38
Calls
$30.6M
Puts
$1.41M
Net Calls
+$29.2M
Net Calls Change
-$842K

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$113M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$98.6M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$53.7M
4
CWP
Capital Wealth Planning
Florida
+$15.6M
5
Goldman Sachs
Goldman Sachs
New York
+$14.3M

Top Sellers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$45M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$29.7M
3
UBS Group
UBS Group
Switzerland
-$24.3M
4
Voloridge Investment Management
Voloridge Investment Management
Florida
-$15M
5
Millennium Management
Millennium Management
New York
-$13.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
IAA
201
Independent Advisor Alliance
North Carolina
$218K +$207K +11,789 New
New York State Common Retirement Fund
202
New York State Common Retirement Fund
New York
$218K – – –
QI
203
Qtron Investments
Massachusetts
$218K – – –
FOA
204
Five Oceans Advisors
California
$216K – – –
FMI
205
Frec Markets Inc
California
$214K +$202K +11,530 New
CSA
206
Cornerstone Select Advisors
Missouri
$213K -$1.72K -98 -0.8%
DWM
207
Drive Wealth Management
Utah
$206K +$196K +11,146 New
HCP
208
Hexagon Capital Partners
Arkansas
$204K +$12.2K +697 +7%
SWP
209
Sagespring Wealth Partners
Tennessee
$204K +$193K +11,016 New
AWM
210
Arista Wealth Management
Nevada
$203K – – –
Carson Wealth (CWM LLC)
211
Carson Wealth (CWM LLC)
Nebraska
$203K +$90.2K +5,137 +88%
BCM
212
Bluefin Capital Management
New York
$202K +$191K +10,900 New
DWM
213
Dynasty Wealth Management
Florida
$195K +$185K +10,533 New
BC
214
Bayforest Capital
United Kingdom
$191K -$82.5K -4,699 -31%
BAM
215
Belpointe Asset Management
Nevada
$188K – – –
FCA
216
Fortis Capital Advisors
Kansas
$188K – – –
X
217
Xponance
Pennsylvania
$188K +$178K +10,134 New
Baird Financial Group
218
Baird Financial Group
Wisconsin
$187K – – –
FPAS
219
Focus Partners Advisor Solutions
Missouri
$186K +$176K +10,049 New
USCWA
220
U.S. Capital Wealth Advisors
Texas
$186K +$176K +10,029 New
WCFA
221
Walkner Condon Financial Advisors
Wisconsin
$186K +$176K +10,021 New
GIC
222
Generali Investments CEE
Czech Republic
$185K – – –
FDCDDQ
223
Federation des caisses Desjardins du Quebec
Quebec, Canada
$184K +$2.49K +142 +1%
EH
224
Equitable Holdings
New York
$181K +$13.6K +773 +7%
AllianceBernstein
225
AllianceBernstein
Tennessee
$167K +$189K +10,742 New
7 8
9
10 11

TAK Hedge Fund Activity: Q1 2026 in Review

358 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Takeda Pharmaceutical (TAK) for Q1 2026, worth a combined $1.82B — up 39% from $1.31B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new TAK positions and 38 closed out — a net gain of 18 holders — while 174 added to existing stakes and 58 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $113M. The largest seller was Arrowstreet Capital, cutting an estimated $45M.

  • 358 institutional investors held Takeda Pharmaceutical (TAK) as of Q1 2026, up from 348 in Q4 2025.
  • Funds reported $1.82B of Takeda Pharmaceutical stock for Q1 2026, up 39% quarter-over-quarter.
  • 56 funds opened new Takeda Pharmaceutical positions in Q1 2026 and 38 closed out, a net change of +18 holders.
  • The largest Takeda Pharmaceutical buyer in Q1 2026 was Adage Capital Partners, an estimated $113M added.
  • The largest Takeda Pharmaceutical seller in Q1 2026 was Arrowstreet Capital, an estimated $45M sold.

Based on aggregated 13F filings for Q1 2026.